secwatch.observer — SEC 8-K summary
======================================

Issuer:     GB SCIENCES INC (—)
CIK:        0001165320
Form:       8-K
Filed at:   2024-07-16T23:59:59+00:00
Accession:  0001437749-24-022794
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GB Sciences appoints Dr. Small-Howard as CEO, CFO, Chairman after John Poss's death
--------------------------------------------------------------------------------

- John Poss passed away on July 10, 2024; he led GB Sciences as CEO and Chairman since 2015.
- Dr. Andrea Small-Howard promoted to CEO, CFO, and Chairman under a pre-established succession plan.
- Dr. Small-Howard previously served as President for three years, overseeing day-to-day operations.
- She is a founding board member and the architect of the company's cannabinoid medicine strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/0001437749-24-022794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1165320/000143774924022794/gblx20240716_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer